Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank57
3Y CAGR-3.4%
5Y CAGR+112.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-3.4%/yr
Annual compound
5Y CAGR
+112.1%/yr
Recent deceleration
Percentile
P57
Within normal range
vs 5Y Ago
43x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $14.39M | +0.5% |
| 2024 | $14.31M | -5.3% |
| 2023 | $15.11M | -5.5% |
| 2022 | $15.98M | -9.2% |
| 2021 | $17.59M | +5150.7% |
| 2020 | $335000.00 | - |
| 2019 | $0.00 | - |
| 2018 | $0.00 | - |